Erlonat(Erlotinib Tablets)

Erlonat 150mg Tablets contain Erlotinib, a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Manufactured by Natco, Erlonat 150 is a targeted therapy that inhibits tyrosine kinase, a protein responsible for cancer cell growth and spread. This treatment is specifically for patients with advanced or metastatic cancers, particularly in cases where other treatments have failed. Erlonat 150 has shown effectiveness in slowing the progression of cancer and improving patient survival rates.

Key benefits include:

• Targets and blocks cancer cell growth
• Enhances survival rates for NSCLC and pancreatic cancer
• Convenient oral tablet form for easy administration
• Trusted formulation by Natco